ANAMARIA ACOSTA: Open Payments
NPI 1851003669 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,684 in 64 payments from 9 companies in 2025. Trend: 2023 $725 · 2024 $1,012 · 2025 $1,684
Food & beverage: $1,667Education: $18
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $444 |
| AstraZeneca Pharmaceuticals LP | 17 | $439 |
| GENZYME CORPORATION | 6 | $267 |
| GlaxoSmithKline, LLC. | 8 | $250 |
| Optinose US, Inc. | 14 | $158 |
| Pharming Healthcare, Inc. | 2 | $44 |
| Itamar Medical Inc | 1 | $33 |
| Medtronic, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $20 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, AIRSUPRA, Xhance, FASENRA, RUCONEST, WatchPATONE.
Industry payments across FL — which companies pay providers there.
